A pilot will offer cholesterol-lowering injections at three East London pharmacies, but wider access depends on its success. The project brings Inclisiran, a medicine that lowers cholesterol, closer to home. It involves Anjis Dispensing Chemist in Waltham Forest and Rohpharm branches in Ilford and Plaistow. The British Heart Foundation funds the project. Barts Health NHS Trust and UCLPartners run it. The people joining have heart disease and need more cholesterol treatment beyond tablets. Many also struggle to attend hospital appointments for injections. The aim is to reduce those hospital visits and make treatment easier to reach. If successful, the scheme could expand to other public health services across the country. The article describes the medicine as a twice-yearly injection under the skin, usually around the stomach. Earlier studies showed it lowers LDL Cholesterol, often called bad cholesterol, by around 50%. That figure comes from studies of the medicine, not from this pharmacy project. This is an access update, not a report of new results. The article gives no blood test changes from people using the pharmacies. It also does not yet show whether the service reduced missed visits. Those are important gaps when judging whether easier access leads to better results. For BioSocial members, this is a useful reason to compare more than bloodwork. Injection dates, test dates, and travel time can add context to your numbers. Sharing those details can help the community compare experiences without assuming everyone will see the same drop. How has getting to injection appointments shaped your treatment experience and the numbers you track?